Company: IXHL
Filing Date: 2025-04-16
Form Type: S-1/A
Source: 0001213900-25-032577
Chunk: 39

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-16
Form: S-1/A
Chunk 39
---
 underlying the ELOC Warrant remain unchanged.

On October 11, 2024, pursuant
to that certain Securities Purchase Agreement, dated September 6, 2024 (the “Debenture Purchase Agreement”), by and between
us and Arena Special Opportunities (Offshore) Master II LP (“Arena Opportunities”), we issued a warrant (the “First
Tranche Warrant”) to purchase up to 453,749 shares of Common Stock to Arena Opportunities. On March 10, 2025, the exercise
price of the First Tranche Warrant was reset to the par value of our Common Stock, which is $0.0001 per share. The number of warrant shares
underlying the First Tranche Warrant remain unchanged.

In connection with the Debenture
Purchase Agreement, we are party to a registration rights agreement, pursuant to which we agreed to file a registration statement, within
twenty days after the first closing date, with the SEC to register the shares of our Common Stock issuable upon (i) the conversion of
10% original issue discount secured convertible debentures, which are no longer outstanding, and (ii) the exercise of warrants issued
pursuant to the Debenture Purchase Agreement. We were previously party to the ELOC Purchase Agreement with Arena Global, pursuant to which,
among other things, we remain obligated to file a registration statement with the SEC within 30 days of the ELOC Purchase Agreement, to
register shares of our Common Stock issuable upon the exercise of warrants issued pursuant to the ELOC Purchase Agreement.

<div align='center'>17</div>

On November 6, 2024, we filed
a registration statement on Form S-3, as amended by a Pre-Effective Amendment No. 1 to Form S-3 on Form S-1, filed on November 26, 2024,
in connection with our obligations pursuant to the ELOC Purchase Agreement and the registration rights agreement entered in connection
with the Debenture Purchase Agreement, which was declared effective by the SEC on December 6, 2024.

In connection with the Private Placement, we are party to the Registration
Rights Agreement, pursuant to which we agreed to use reasonable best efforts to register the PIPE Shares, Pre-Funded Warrant Shares and
Series A Warrant Shares for resale within thirty (30) days of the filing date of the registration statement. We filed the registration
statement of which this prospectus forms a part in connection with these obligations.